Clinical Trial Update: The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pomalidomide with cyclophosphamide and dexamethasone (PCD) for transplant-ineligible relapsed/refractory multiple myeloma has been comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• And or Refractory Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Kosin University Gospel Hospital | Conditions: Relapsed and/or refractorY Multiple Myeloma | Phase 2 | Status: COMPLETED